GPT Healthcare Limited – Globe Capital Market LTD.
GPT Healthcare Limited
Closed
Price Band
₹177 to ₹186
IPO Issue Period
Feb 22, 2024 to Feb 26, 2024
Issue Size
₹525.14 Cr
Face value
10
Fresh issue
₹40.00 Cr
Offer for sale
₹485.14
Minimum Shares for Retail
80 Shares
Listing on
NSE, BSE
Issue Type
Book Building
Registrar to the Issue
Link Intime India Private Ltd
Tentative Listing Date
Feb 29, 2024
QIB
50%
NII
15%
Retail
35%

Jm Financial Limited

Incorporated in 1989, GPT Healthcare Limited operates a chain of mid-sized, multi-specialty, full-service hospitals in Eastern India under the ILS Hospitals brand, providing integrated healthcare services focusing on secondary and tertiary care.

Based in Kolkata, West Bengal, the company offers a range of healthcare services in over 35 specialties and super-specialties, including internal medicine and diabetology, nephrology (including kidney transplant), laparoscopic and general surgery, gynaecology and obstetrics, intensive care, gastroenterology, orthopaedics and joint replacement, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology. It also offers integrated diagnostic services and pharmacies.

GPT Healthcare’s hospitals are located in four cities, namely

  • Salt Lake, Kolkata (West Bengal) with a capacity of 85 beds, including 17 beds in various ICUs and HDUs (as of June 30, 2023)
  • Agartala (Tripura) with a capacity of 205 beds (as of June 30, 2023), including 66 beds in various ICUs and HDUs
  • Dum Dum, Kolkata (West Bengal) with a capacity of 155 beds, including 53 beds in various ICUs and HDUs as of June 30, 2023
  • Howrah (West Bengal) with a capacity of 116 beds, including 43 beds in various ICUs and HDUs, as of June 30, 2023.

As at June 30, 2023, the company operates four multidisciplinary hospitals with a total capacity of 561 beds, offering a comprehensive range of healthcare services in over 35 specialties and super-specialties.

As at June 30, 2023, the company had 1,855 employees, 85 full-time consultants, and 465 visiting consultants.

 

For year/ period ended ( in Cr.)

Particulars H1FY23 FY22 FY21
Total Revenue 366.73 342.40 248.86
Profit After Tax 39.01 41.66 21.09
EPS 4.88 5.21 2.64
OPM (%) 18.87% 21.83% 23.02%
PATM (%) 9.73% 10.64% 26.34%

 

For year/ period ended ( in Cr.)

Company Name Market Cap (Cr.) Price P/BV P/E Sales (Cr.)
FY23
Net Profits(Cr.)
FY23
GPT Healthcare Ltd. *1526 186 9.05 38.11 361.0 39.0
Global Health Ltd. 37,604 1,401 13.54 83.22 3153.0 451.8
Krishna Institute of Medical Sciences Ltd 17,982 2,247 9.52 53.21 2440.3 363.3
Shalby Ltd. 3,233 299 3.29 39.72 888.5 81.4

 

*Market cap @upper band 

  • Key regional corporate healthcare company with a strong foothold in under-penetrated and densely populated healthcare delivery markets
  • ‘Right-sized’, full service and strategically located hospitals leading to high return on capital
  • Well diversified specialty mix and location mix
  • Ability to attract, train and retain quality medical professionals
  • Track record of operating and financial performance and growth
  • Professional management and experienced leadership
  • Investment in infrastructure, processes and clinical excellence driving affordability, and a strong value proposition for stakeholders
  1. Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company from banks and financial institutions; and
  2. General corporate purposes.

At the upper band of Rs. 186, the stock is trading at P/E multiple of 38.11 times. Investors may park funds for the medium to long term rewards.

Be a Part of IPO Success Stories!

Never Miss IPO Investment